| IntOGen-mutations identifies cancer drivers across tumor types A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ... Nature methods 10 (11), 1081-1082, 2013 | 603 | 2013 |
| The mutational landscape of chromatin regulatory factors across 4,623 tumor samples A Gonzalez-Perez, A Jene-Sanz, N Lopez-Bigas Genome biology 14, 1-15, 2013 | 135 | 2013 |
| IntOGen: integration and data mining of multidimensional oncogenomic data G Gundem, C Perez-Llamas, A Jene-Sanz, A Kedzierska, A Islam, ... Nature methods 7 (2), 92-93, 2010 | 133 | 2010 |
| Expression of polycomb targets predicts breast cancer prognosis A Jene-Sanz, R Váraljai, AV Vilkova, GF Khramtsova, AI Khramtsov, ... Molecular and cellular biology 33 (19), 3951-3961, 2013 | 45 | 2013 |
| Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer J Ingles-Esteve, M Morales, A Dalmases, R Garcia-Carbonell, ... PloS one 7 (5), e38347, 2012 | 34 | 2012 |
| 455: The role of new cancer hallmarks in tumorigenesis A Gonzalez-Perez, A Jene-Sanz, D Tamborero, N Lopez-Bigas European Journal of Cancer 50, S110, 2014 | 2 | 2014 |
| EZH2 expression in different subtypes of human breast cancer GF Khramtsova, AB Islam, AI Khramtsov, P Lyman, L Chuanhong, ... Cancer Research 72 (8_Supplement), 1061-1061, 2012 | | 2012 |
Nuria Lopez-BigasICREA Research Professor at the Institute for Research in BiomedicineCorreu electrònic verificat a irbbarcelona.org
